SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018521
Filing Date
2019-05-10
Accepted
2019-05-10 16:02:30
Documents
47
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q wve-10q_20190331.htm 10-Q 1135718
2 EX-10.1 wve-ex101_353.htm EX-10.1 62243
3 EX-10.2 wve-ex102_352.htm EX-10.2 63196
4 EX-31.1 wve-ex311_9.htm EX-31.1 14713
5 EX-31.2 wve-ex312_7.htm EX-31.2 15039
6 EX-32 wve-ex32_8.htm EX-32 9143
7 GRAPHIC gro2aaqh34ti000001.jpg GRAPHIC 42836
  Complete submission text file 0001564590-19-018521.txt   3221366

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT wve-20190331.xml EX-101.INS 328040
9 XBRL TAXONOMY EXTENSION SCHEMA wve-20190331.xsd EX-101.SCH 32986
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20190331_cal.xml EX-101.CAL 42160
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20190331_def.xml EX-101.DEF 73350
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20190331_lab.xml EX-101.LAB 252244
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20190331_pre.xml EX-101.PRE 173033
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 19814796
SIC: 2834 Pharmaceutical Preparations